Abstract

Bacterial co-pathogens are commonly identified in viral respiratory infections and are important causes of morbidity and mortality. The prevalence of bacterial infection in patients infected with SARS-CoV-2 is not well understood. To determine the prevalence of bacterial co-infection (at presentation) and secondary infection (after presentation) in patients with COVID-19. We performed a systematic search of MEDLINE, OVID Epub and EMBASE databases for English language literature from 2019 to April 16, 2020. Studies were included if they (a) evaluated patients with confirmed COVID-19 and (b) reported the prevalence of acute bacterial infection. Data were extracted by a single reviewer and cross-checked by a second reviewer. The main outcome was the proportion of COVID-19 patients with an acute bacterial infection. Any bacteria detected from non-respiratory-tract or non-bloodstream sources were excluded. Of 1308 studies screened, 24 were eligible and included in the rapid review representing 3338 patients with COVID-19 evaluated for acute bacterial infection. In the meta-analysis, bacterial co-infection (estimated on presentation) was identified in 3.5% of patients (95%CI 0.4-6.7%) and secondary bacterial infection in 14.3% of patients (95%CI 9.6-18.9%). The overall proportion of COVID-19 patients with bacterial infection was 6.9% (95%CI 4.3-9.5%). Bacterial infection was more common in critically ill patients (8.1%, 95%CI 2.3-13.8%). The majority of patients with COVID-19 received antibiotics (71.9%, 95%CI 56.1 to 87.7%). Bacterial co-infection is relatively infrequent in hospitalized patients with COVID-19. The majority of these patients may not require empirical antibacterial treatment.

Keywords

MedicineMeta-analysisInternal medicineCoronavirus disease 2019 (COVID-19)Respiratory tract infectionsAntibioticsLower respiratory tract infectionImmunologyRespiratory systemMicrobiologyBiologyInfectious disease (medical specialty)Disease

MeSH Terms

AsiaBacteriaBacterial InfectionsCOVID-19CoinfectionCritical IllnessData ManagementFemaleHumansMalePandemicsPrevalenceRespiratory Tract InfectionsUnited States

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
review
Volume
26
Issue
12
Pages
1622-1629
Citations
1571
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1571
OpenAlex
85
Influential
1207
CrossRef

Cite This

Bradley J. Langford, Miranda So, Sumit Raybardhan et al. (2020). Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clinical Microbiology and Infection , 26 (12) , 1622-1629. https://doi.org/10.1016/j.cmi.2020.07.016

Identifiers

DOI
10.1016/j.cmi.2020.07.016
PMID
32711058
PMCID
PMC7832079

Data Quality

Data completeness: 90%